HURLSTON MICHAEL E. 4

What Happened Michael Hurlston, a director of Astera Labs, was granted 837 restricted stock units (RSUs) on June 4, 2026. The RSUs were awarded at $0.00 per unit (total immediate value $0); each RSU represents a contingent right to one share of Astera Labs common stock upon vesting. This was a grant/award (not a purchase or sale).

Key Details

• Transaction date: June 4, 2026; Form 4 filed June 8, 2026.
• Grant: 837 RSUs at $0.00 (acquisition code A on the filing).
• Total immediate cash value: $0 (award, not a cash transaction).
• Vesting terms (Footnote 1): RSUs vest in full on the earlier of (i) the first anniversary of the grant date or (ii) the next annual stockholder meeting, subject to continuous service.
• Footnote 2: Ownership reported in the filing may include deferred stock units and dividend equivalent units.
• Shares owned after transaction: Not specified in the summary data provided; see the SEC filing for the post-transaction holdings and any additional ownership details.
• Filing timeliness: Form 4 was filed four days after the grant date; consult the SEC filing for any tardiness notation.

Context RSU grants are a form of compensation and do not involve an immediate purchase or sale of stock. Each RSU converts to one share only upon vesting under the stated time-based conditions; therefore this award does not immediately change market exposure for the director. Grants to directors are common as part of compensation and should be interpreted as compensation-related rather than direct market sentiment.